Corcept Therapeutics
CORT
#2254
Rank
NZ$14.94 B
Marketcap
NZ$139.17
Share price
-2.25%
Change (1 day)
17.23%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$1.11 Billion

According to Corcept Therapeutics 's latest financial reports the company has NZ$1.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$1.11 B-7.18%
2024-12-31$NZ$1.20 B50.39%
2023-12-31$NZ$0.80 B1.37%
2022-12-31$NZ$0.79 B43.66%
2021-12-31$NZ$0.55 B-24.14%
2020-12-31$NZ$0.72 B31.6%
2019-12-31$NZ$0.55 B34%
2018-12-31$NZ$0.41 B52.96%
2017-12-31$NZ$0.26 B350.13%
2016-12-31$NZ$59.73 M121.02%
2015-12-31$NZ$27.02 M-725.04%
2014-12-31$-NZ$4.33 Million-116.91%
2013-12-31$NZ$25.57 M-65.94%
2012-12-31$NZ$75.09 M68.38%
2011-12-31$NZ$44.59 M61.96%
2010-12-31$NZ$27.53 M-9.47%
2009-12-31$NZ$30.41 M4.4%
2008-12-31$NZ$29.13 M51.46%
2007-12-31$NZ$19.23 M113.07%
2006-12-31$NZ$9.02 M-76.8%
2005-12-31$NZ$38.9 M-39.58%
2004-12-31$NZ$64.39 M-233%
2003-12-31$-NZ$48.42 Million15.49%
2002-12-31$-NZ$41.93 Million-177.8%
2001-12-31$NZ$53.88 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$141.39 B 12,625.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$67.79 B 6,001.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$157.44 B 14,070.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.33 B 4,790.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$79.99 B 7,099.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$35.00 B 3,050.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$0.11 Billion-109.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$0.79 Billion-170.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$10.81 B 873.70%๐Ÿ‡บ๐Ÿ‡ธ USA